Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer science

Showing results (661-670 of 7,111) with videos related to

Pageof 712
Sort By:
Cancer Science|January 21, 2010
Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis: a retrospective studyKohei Shitara, Keitaro Matsuo, Shunzo Hatooka, et al.
Cancer Science|January 21, 2010
Bmi-1 gene is upregulated in early-stage hepatocellular carcinoma and correlates with ATP-binding cassette transporter B1 expressionKathryn Effendi, Taisuke Mori, Mina Komuta, et al.
Cancer Science|January 22, 2010
Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatmentHidenori Ojima, Daitaro Yoshikawa, Yoshihiro Ino, et al.
Cancer Science|January 6, 2010
Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147Pu Zhao, Wei Zhang, Juan Tang, et al.
Cancer Science|November 18, 2009
Histological type of Thorotrast-induced liver tumors associated with the translocation of deposited radionuclidesYoichiro Yamamoto, Junichi Chikawa, Yoshinobu Uegaki, et al.
Cancer Science|November 18, 2009
Novel human papillomavirus type 18 replicon and its application in screening the antiviral effects of cytokinesAyano Satsuka, Satoshi Yoshida, Naoko Kajitani, et al.
Cancer Science|November 26, 2009
Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancerMotoki Miyazawa, Ryuji Ohsawa, Takuya Tsunoda, et al.
Cancer Science|April 27, 2017
Co-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapyYaqing Li, Yinting Chen, Jiajia Li, et al.
Cancer Science|April 27, 2017
Glucose metabolism-targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor-induced drug-tolerant persistersKei Kunimasa, Tatsuya Nagano, Yohei Shimono, et al.
Cancer Science|April 26, 2017
Roles of the PDZ-binding motif of HPV 16 E6 protein in oncogenic transformation of human cervical keratinocytesYuki Yoshimatsu, Tomomi Nakahara, Katsuyuki Tanaka, et al.
Pageof 712

Showing results (661-670 of 7,111) with videos related to

Sort By:
Pageof 712
Cancer Science|January 21, 2010
Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis: a retrospective studyKohei Shitara, Keitaro Matsuo, Shunzo Hatooka, et al.
Cancer Science|January 21, 2010
Bmi-1 gene is upregulated in early-stage hepatocellular carcinoma and correlates with ATP-binding cassette transporter B1 expressionKathryn Effendi, Taisuke Mori, Mina Komuta, et al.
Cancer Science|January 22, 2010
Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatmentHidenori Ojima, Daitaro Yoshikawa, Yoshihiro Ino, et al.
Cancer Science|January 6, 2010
Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147Pu Zhao, Wei Zhang, Juan Tang, et al.
Cancer Science|November 18, 2009
Histological type of Thorotrast-induced liver tumors associated with the translocation of deposited radionuclidesYoichiro Yamamoto, Junichi Chikawa, Yoshinobu Uegaki, et al.
Cancer Science|November 18, 2009
Novel human papillomavirus type 18 replicon and its application in screening the antiviral effects of cytokinesAyano Satsuka, Satoshi Yoshida, Naoko Kajitani, et al.
Cancer Science|November 26, 2009
Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancerMotoki Miyazawa, Ryuji Ohsawa, Takuya Tsunoda, et al.
Cancer Science|April 27, 2017
Co-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapyYaqing Li, Yinting Chen, Jiajia Li, et al.
Cancer Science|April 27, 2017
Glucose metabolism-targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor-induced drug-tolerant persistersKei Kunimasa, Tatsuya Nagano, Yohei Shimono, et al.
Cancer Science|April 26, 2017
Roles of the PDZ-binding motif of HPV 16 E6 protein in oncogenic transformation of human cervical keratinocytesYuki Yoshimatsu, Tomomi Nakahara, Katsuyuki Tanaka, et al.
Pageof 712